Cargando…
B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma
Secondary acute lymphoblastic leukemia (ALL) is a rare disease that has not been well characterized compared with secondary myelodysplastic syndrome or secondary acute myeloid leukemia. We present a report of two patients who developed ALL following complete remission of diffuse large B-cell lymphom...
Autores principales: | Gaut, Daria, Bejjani, Anthony, Sasine, Joshua, Schiller, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589539/ https://www.ncbi.nlm.nih.gov/pubmed/31285810 http://dx.doi.org/10.4081/hr.2019.8100 |
Ejemplares similares
-
Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature
por: Gaut, Daria, et al.
Publicado: (2018) -
Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma
por: Lee, Ha-young, et al.
Publicado: (2014) -
Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma
por: Demiriz, Itır Şirinoğlu, et al.
Publicado: (2014) -
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
por: Thudium Mueller, Karen, et al.
Publicado: (2021) -
Filgrastim associations with CAR T‐cell therapy
por: Gaut, Daria, et al.
Publicado: (2020)